Baxter Joins Big Pharma Funds on $38MB Round for Naurex Anti–depression R&D
Baxter joins Big Pharma funds on MB round for Naurex anti–depression R&D
Baxter's new venture fund has stepped up to take the lead on a $ 38 million B round for Naurex, an Evanston, IL-based biotech prepping for a Phase IIb study of its lead anti-depressant, which has already attracted the support of three big corporate funds. Read more on FierceBiotech
Get fit with Ludas
“It helped me come off medication because the positive feelings I get are far better than being on anti-depressants.” The charity's work also aims to reach people across Lancashire and the North West by creating opportunities through dance and working … Read more on Lancaster Today
Anti Depression / Anxiety & Stress (Isochronic) – You have the right to be happy! Anti Depression, Anti Anxiety, Anti Stress Isochronic Tones. Enjoy!